Find a company
Search the SBRI Healthcare and NHS Cancer Programme Innovation Open call portfolio.
If you would like further information on any of the companies listed in the Directory please contact the SBRI Healthcare PMO by email sbri@lgcgroup.com or tel: +44 20 8843 8125.
We would be happy to make introductions to the companies or provide any further feedback you require.
At a glance
Directory search results
The Essential Baby Company
Project | haPPIE™ SHE Cares |
---|---|
Description |
haPPIE: SHE Cares project aims to enhance mental health support for Black and Ethnically |
Funding | £ 77,098 |
Competition | Competition 25 - Women's health |
Competition Date | July 2024 |
Categories | Women's health |
Health Innovation Network Partner | Health Innovation East Midlands |
Website | www.theessentialbabyco.com |
Neotherix Limited
Project | Co-designing improved treatment for recto-vaginal fistula; investigating the needs of women and assessing the feasibility of a novel, cost-effective device |
---|---|
Description |
Neotherix is an SME dedicated to developing solutions for problem wounds based on electrospun scaffolds. This project explores the feasibility of developing a novel device for recto-vaginal fistula treatment. Building on work conducted in fistula-in-ano, in collaboration with University of Birmingham, University Hospitals Birmingham NHS Trust, and SME Keighleycolo Ltd, the postulated device integrates a drainage seton with a bioresorbable scaffold to promote more effective drainage and repair. It aims to reduce the need for multiple surgeries and hospital admissions, improving patient outcomes with a less invasive approach. |
Funding | £ 99,981 |
Competition | Competition 25 - Women's health |
Competition Date | July 2024 |
Categories | Women's health |
Website | https://www.neotherix.com/ |
Queen Mary University of London & Samphire Neuroscience
Project | Validation of a Non-Invasive Brain Stimulation Device (Nettle) to Manage Symptoms of Premenstrual Dysphoric Disorder |
---|---|
Description |
Nettle, is a Class-IIa, CE-marked, drug-free, hormone-free, Bluetooth-controlled wearable transcranial direct current stimulation (tDCS) device developed by women at Samphire Neuroscience, and is tailored to women’s needs. Nettle provides non-invasive stimulation to both the motor cortex (to alleviate physical pain) and the prefrontal cortex (to improve symptoms of mood disorders). Use of Nettle during the final two weeks of the menstrual cycle has been shown to relieve pain and low mood associated with dysmenorrhea (painful menstrual cramps), premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). |
Funding | £ 88,811 |
Competition | Competition 25 - Women's health |
Competition Date | July 2024 |
Categories | Women's health |
Health Innovation Network Partner | Health Innovation Network South London |
Website | https://samphireneuro.com/ |